In modern assisted reproductive technology, the "whole embryo freezing" strategy was once considered a standard operation for optimizing success rates. However, as clinical research deepens, an important fact gradually becomes clear: this "one size fits all" approach is not a panacea, especially for women whose ovarian reserve function has declined. Prioritizing fresh embryo transfer may be the shortest path to success.
The "deified" vitrification freezing technology
Undoubtedly, vitrification freezing is a major milestone in reproductive medicine, as it allows embryos to "pause life" at ultra-low temperatures, with a recovery survival rate of over 95%. This technology provides valuable flexibility for many families: they can wait for pre implantation genetic testing (PGT), allow the body to recover from the stress state of ovulation induction, or postpone transplantation plans due to personal reasons.
However, the popularization of technology has also given rise to a clinical inertia. Many reproductive centers default to using the "whole embryo freezing" program, but may overlook its core principle: individualized treatment. Especially for "low prognosis" patients who have a small number of eggs retrieved each time and whose ovarian function is racing against time, this standardized waiting may mean a loss of opportunity.
Real case: 38 year old Ms. Wang's choice transformation
Ms. Wang is a 38 year old corporate executive who has experienced two failed IVF cycles at other reproductive centers due to decreased ovarian reserve function (AMH value of only 0.8ng/ml). Her previous plans were all "whole embryo freezing", with the reason being that "freezing the transplanted endometrium environment is better". However, she could only obtain 1-2 embryos each time, and after freezing and resuscitation, the quality of the embryos was not ideal during the final transfer, and both attempts failed to implant.
With doubts, Ms. Wang came to the Tulip International Reproductive Center. After a detailed evaluation of her medical history and physical condition, our expert team proposed a different strategy: if conditions permit in this cycle, priority should be given to fresh embryo transfer.
The tulip expert explained that for patients like Ms. Wang who have very few retrieved eggs, each embryo is extremely precious. The freezing and thawing process, even if the technology is mature, is still a consumption of energy and potential for the embryo. Instead of letting the already precious embryo bear this risk, it is better to allow it to return directly to the mother's body in the most active and natural state after egg retrieval, under ideal conditions for various bodily indicators, especially progesterone levels and endometrial status.
In the end, Ms. Wang obtained 2 high-quality embryos in the new cycle. On the fifth day after egg retrieval, her progesterone levels were normal, and the thickness and morphology of the endometrium were excellent, fully meeting the transplantation criteria. The medical team performed a fresh transfer of one blastocyst for her, while the other was frozen.
Ten days later, the pregnancy test was successful. Ms. Wang's experience is a vivid proof of the superiority of individualized solutions over standardized processes.
Scientific interpretation: Why should low prognosis patients not blindly freeze?
The freezing loss of embryos is a real phenomenon
Although vitrification freezing technology greatly reduces physical damage, the freezing and thawing process may still have microscopic effects on embryos.
The impact on low-quality embryos is more significant: for embryos with fewer cells and higher fragmentation rates, the stress response during the freezing process may be greater, affecting their subsequent developmental potential.
Delayed recovery of metabolic activity: Resuscitated embryos require time to "restart" their cellular metabolic activity, which may result in slight asynchrony with the optimal "implantation window" of the endometrium.
Potential changes in epigenetics: Studies have shown that low-temperature processes may affect epigenetic modifications such as DNA methylation in embryos, which are closely related to the correct expression of genes.
Time cost: irreversible countdown to ovarian function
For women with ovarian dysfunction, time is the most precious resource. Choosing frozen transplantation means a waiting period of at least 1-2 months. During this period, ovarian function may undergo further irreversible decline, affecting the effectiveness of the next treatment cycle or even completely losing the opportunity.
The 'natural advantage' of fresh cycles
Fresh embryos, without any low-temperature treatment, are at the peak of their vitality. More importantly, in the fresh transplantation cycle, the corpus luteum formed in the female body after promoting ovulation can secrete natural progesterone and estrogen. This endogenous hormone support can sometimes provide a physiologically more "harmonious" uterine environment for embryo implantation than the endocrine environment simulated by completely relying on exogenous drugs in artificial cycles.
Data support from authoritative research
A heavyweight study published in the American Journal of Obstetrics and Gynecology (AJOG) analyzed nearly 2000 patients with ovarian dysfunction and found that for populations with ≤ 5 retrieved eggs, the live birth rate of fresh embryo transfer (23.3%) was significantly higher than that of frozen embryo transfer (15.6%).
Another study found that in patients with anti Mullerian hormone (AMH) levels<1.1ng/ml, the clinical pregnancy rate in the fresh transplant group was nearly 10 percentage points higher than that in the frozen group.
A large-scale meta-analysis in 2020 also confirmed that in the patient population defined as "Poor Responders," the cumulative live birth rate of fresh transplants was 15-20% higher than that of whole embryo freezing strategies.
How to choose? A clear decision-making guide
At Tulip International Reproductive Center, we firmly believe that the selection of a plan must be based on the individual circumstances of the patient.
Prioritize the golden indication of 'fresh transplantation':
Decreased ovarian reserve function (such as AMH<1.1 ng/ml or basal antral follicle count AFC<5).
Expected low number of retrieved eggs (usually<5), or age>38 years old.
History of failed frozen embryo transfer in the past.
After egg retrieval, hormone levels are ideal, especially progesterone levels are normal (usually<1.5 ng/ml).
The thickness and morphology of the endometrium are good (thickness>7mm, showing clear trilinear sign).
There is no risk of moderate to severe ovarian hyperstimulation syndrome (OHSS).
Clearly specify the situation where 'frozen transplantation' needs to be selected:
There is a high risk of ovarian hyperstimulation syndrome (OHSS), such as having more than 15 retrieved eggs and high estrogen levels.
Pre implantation genetic testing (PGT) is required.
During the egg retrieval cycle, premature elevation of progesterone levels (>1.5 ng/ml) leads to premature transformation of the endometrium, which is not synchronized with embryonic development.
During the fresh cycle, it was found that the endometrium was poor (such as thin endometrium, presence of polyps, uterine fluid accumulation, etc.).
Due to personal or other medical reasons, transplantation cannot be performed during the current cycle.
The success path of in vitro fertilization is not blindly following a certain technological trend, but rather doctors and patients making the wisest decisions based on scientific evidence and individual differences. If you are also a 'low prognosis' patient striving for fertility, remember that delving into the possibility of fresh transplantation with your doctor may be a crucial step in opening the door to success.
For fertility consultation in Kyrgyzstan, please contact your dedicated consultant
/Fertility Consultation /
Dr.Chan
Copy and add: Tulip_EnoChan
Or long press/scan the QR code to add
Tulip International Fertility Center
Technology aids fertility, fulfilling dreams for countless families
